Novartis reported $2.17B in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Alcon AG ALC:SW USD 205M 5M
Amgen AMGN:US USD 2.74B 562M
Artemis Alpha ATS:LN GBP -26696000 16.49M
AstraZeneca AZN:LN USD 1.25B 706M
Bayer BAYN:GR EUR 1.2B 1.03B
Biogen BIIB:US USD 1.32B 1.37B
Bristol Myers Squibb BMY:US USD 2.47B 117M
Eli Lilly And LLY:US USD 1.68B 466.4M
Fresenius FRE:GR EUR 887M 42M
Fresenius Medical Care FME:GR EUR 472M 131M
Galapagos GLPG:NA EUR -37578000 38.75M
Genmab GEN:DC DKK 1.93B 684M
Gilead Sciences GILD:US USD 2.84B 808M
GlaxoSmithKline GSK:LN GBP 1.19B 110M
Hikma Pharmaceutical HIK:LN USD 249M 6M
Johnson & Johnson JNJ:US USD 5.82B 18M
Lonza Group LONN:SW CHF 645M 111M
Merck MRK:GR EUR 1.23B 57M
Merk MRK:US USD 3.99B 939M
Novartis NOVN:VX USD 2.17B 60M
Novartis NVS:US USD 2.17B 60M
Orion ORNBV:FH EUR 245.4M 163.4M
Pfizer PFE:US USD 9.41B 2.69B
Philips PHIA:NA EUR -1529000000 1.54B
Recordati REC:IM EUR 122.7M 23.57M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M